A prospective study of hepatitis C virus infection after needlestick accidents

Liver

Volumn 16, Issue 5, 1996, Pages 331-334

  Arai, Yumi ^a   Noda, Katsuhisa ^a   Enomoto, Norihiro ^a   Arai, Keiichi ^a   Yamada, Yukinori ^a   Suzuki, Kunio ^a   Yoshihara, Harumasa ^a  

^a OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

HCV antibody; HCV RNA; Hepatitis C virus; Interferon therapy; Needlestick accidents

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NEEDLESTICK INJURY; PREVALENCE; PROSPECTIVE STUDY; VIRUS DETECTION;

EID: 0029859366     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00755.x     Document Type: Article

References (24)

1. SEEFF L B, WRIGHT E C, ZIMMERMAN H J, et al. Type B hepatitis after needlestick exposure: prevention with hepatitis B immune globulin: final report of the Veterans Administration cooperative study. Ann Intern Med 1978: 88: 285-293.
2. SEEFF L B, HOOFSNGLE J H. Immunoprophylaxis of viral hepatitis. Gastroenterol 1979: 77: 161-182.
3. KIYOSAWA K, GIBO G, SODEYAMA T, et al. Possible infectious causes in 651 patients with acute viral hepatitis during a 10-year period (1976-1985). Liver 1987: 7: 165-168.
4. ALTER M J, GERETY R J, SMALLWOOD L A, et al. Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban US population. J Infect Dis 1982: 145: 886-893.
5. GERBERDING J L. Current epidemiologic evidence and case reports of occupationally acquired HIV and other blood borne disease. Infect Control Hosp Epidemiol 1990: 11: 558-560.
6. AHTONE J, FRANCIS D, BRADLEY D, MAYNARD J. Non-A, non-B hepatitis in a nurse after percutaneous needle exposure. Lancet 1980: 1: 1142.
7. HERRON W, PETERSON E, TAYLOR J W. Non-A, non-B hepatitis infection transmitted via a needle. MMWR 1978: 28: 157-158.
8. MAYO-SMITH M F. Type non-A, non-B and type B hepatitis transmitted by a single needlestick. Am J Infect Control 1987: 15: 266-267.
9. VAGLIA A, NICOLIN R, PURO V, IPPOLITO G, BETTINI C, DELALLA H. Needlestick hepatitis C virus seroconversion in a surgeon. Lancet 1990: 36: 1315-1316.
10. SCHLIPKOTER U, ROGGENDORF M, CHOLMAKOW K, WEISE A, DEINHARDT F. Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scand J Infect Dis 1990: 22: 757-758.
11. KIYOSAWA K, SODEYAMA T, TANAKA E, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med 1991: 115: 367-369.
12. CARIANI E, ZONARO A, PRIMI D, et al. Detection of HCV/ RNA and antibodies to HCV after needlestick injury. Lancet 1991: 337: 850.
13. SODEYAMA T, KIYOSAWA K, URUSHIHARA A, et al. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 1993: 153: 1565-1572.
14. FUKUI T, NODA H, HINAMI F, et al. Blood contamination for medical staff and positive rate of HCV antibody in inpatients. Jpn J Traumatol Occup Med 1992: 40: 603-607.
15. OSADA K, SAMESHIMA Y, FUJII H, SHIMIZU M, WATANABE J, NISHIOKA K. Effect of donor blood screening for anti-HCV antibody by the second-generation passive hemagglutination test on the incidence of post-transfusion hepatitis. In: Nishioka, ed. Viral hepatitis and liver disease. Hong Kong: Springer-Verlag Tokyo Publishing, 1994: 562-564.
16. ULRICH P P, ROMEO J M, LANE P K, KELLY I, DANTEL W, VYAS G N. Detection, semiquantitation, and genetic variation in hepatitis C virus sequence amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest 1990: 86: 1609-1614.
17. GILLILAND G, PERRIN S, BLANCHARD K, BUNN H F. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990: 87: 2725-2729.
18. OKAMOTO H, SUGIYAMA Y, OKADA S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992: 73: 673-679.
19. U.S. National Heart and Lung Institute Collaborative Study Group and Phoenix Laboratories Division, Bureau of Epidemiology, Center for Disease Control. Relation of e antigen to infectivity of HBsAg-positive inoculations among medical personnel. Lancet 1976: 2: 492.
20. YOSHIZAWA H, ITOH Y, IWASAKI S, et al. Non-A, non-B (type 1) hepatitis agent capable of inducing tubular structures in the hepatocyte cytoplasm of chimpanzees: inactivation by formalin and heat. Gastroenterol 1982: 82: 502-506.
21. SHIKATA T, KARASAWA T, ABE K, et al. Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis 1977: 136: 571-576.
22. KATO N, YOKOSUKA O, HOSODA K, ITO Y, OHTA M, OMATA M. Detection of hepatitis C virus in acute non-A, non-B hepatitis as an early diagnostic tool. Biochem Biophys Res Comm 1993: 192: 800-807.
23. OMATA M, YOKOSUKA O, TAKANO S, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991: 338: 914-915.
24. KORETZ R L, STONE Q, GITNICK G L. The long-term course of non-A, non-B post-transfusion hepatitis. Gastroenterol 1980: 79: 893-898.